The present invention relates to a process for the preparation of polyaminocarboxylic acids, in particular phenolic aryl- or alkyldiaminepolycarboxylic acids, preferably a compound of formula (I): wherein X is selected from the group consisting of: H, COOH, COO.sup.−Y.sup.+, OH, linear or branched C.sub.1-C.sub.5 alkyl, CH.sub.2OH, SO.sub.3H, SO.sub.3.sup.−Y.sup.+, wherein: —Y.sup.+ is independently selected from the group consisting of: Li.sup.+, Na.sup.+, K.sup.+, and NH.sub.4.sup.+; and wherein A is selected from: —A (CH.sub.2)n linear aliphatic system, wherein n=2, 3 or 4, preferably 2 or 3; and —an aromatic system of formula (II): wherein R1, R2 are independently selected from the group consisting of H, OH, and linear or branched C.sub.1-C.sub.5 alkyl; said process comprising the step of reacting, a phenol compound, glyoxylic acid and an aryl- or alkyldiamine in the presence of an iron source to obtain a reaction mixture comprising the compound of formula (I). The invention also relates to a process for the preparation of a chelate compound, which is a complex of the compound of formula (I) with iron.

The titanium (IV) and iron (III) MOF solid MUV-17 (TiFe.sub.2), has general formula (1): [Ti.sup.IVFe.sup.III.sub.2(O)(L).sub.2(X).sub.3]S, where X is each equal or different selected from: O.sup.2−, OH.sup.−, H.sub.2O, F.sup.−, Cl.sup.−, Br.sup.−, I.sup.−, NO.sub.3.sup.−, ClO.sub.4.sup.−, BF.sub.4.sup.−, SCN.sup.−, OH.sup.−, CH.sub.3COO.sup.−, C.sub.5H.sub.7O.sub.2.sup.−, SO.sub.4.sup.2− and CO.sub.3.sup.2−, L is a tricarboxylic ligand and S is at least one molecule of a polar solvent selected from the group consisting of N,N′-dimethylformamide,N,N′-diethylformamide,N,N′-dimethylacetamide, N-methyl-2-pyrrolidone, methanol, ethanol, isopropanol, n-propanol, water and mixtures thereof. The titanium (IV) and iron (III) MOF solid has long-term catalytic activity for the degradation of toxic compounds. The method for obtaining them comprises dissolving the components under anaerobic conditions. The invention also relates to the use of the titanium (IV) and iron (III) MOF solid as an additive with detoxifying properties of toxic compounds.

A binuclear Fe(III) fused porphyrin. Synthesizing the binuclear fused porphyrin includes combining free-base fused-porphyrin and a solvent to yield a solution, refluxing the solution, combining a metal salt with the solution, and removing the solvent from the solution.

Embodiments of the present disclose provide a method of sorbing one or more compounds from a fluid, wherein the method may include contacting a M-soc-MOF composition with a fluid containing at least H.sub.2S and one or more of CO.sub.2 and CH.sub.4; and sorbing at least H.sub.2S from the fluid. Embodiments of the present disclosure provide a membrane that may include a metal-organic framework (MOF) composition, wherein the MOF composition includes a M-soc-MOF composition, where M is a metal and soc is a square-octahedral topology, and wherein the M-soc-MOF composition is a continuous thin film on a support.

The present invention relates to an iron complex having the general formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to a pharmaceutical composition formulated for oral and/or parenteral administration, preferably intravenous, said pharmaceutical composition preferably being formulated as an aqueous solution comprising said complex or salt. The present invention further relates to said complex or a salt thereof or said pharmaceutical composition for use as a contrast agent for magnetic resonance imaging (MRI), as well as a method and a kit for in situ preparation of said complex or salt and said pharmaceutical composition.

Activated ferrate solutions, methods of their preparation, and methods of disinfecting surfaces and oxidizing pollutants in water are provided.

A pyrazole metal complex for absorption of carbon dioxide, a method for preparing the pyrazole metal complex, and a method for absorbing carbon dioxide are provided; wherein the product produced by reacting pyrazole metal complex and carbon dioxide may be transformed into several economically valuable compounds.

Nanoparticles that can be used as hydrosilylation and dehydrogenative silylation catalysts. The nanoparticles have at least one transition metal with an oxidation state of 0, chosen from the metals of columns 8, 9 and 10 of the periodic table, and at least one carbonyl ligand, preferably a silicide.

Disclosed are a pincer-type ligand having a structurally rigid acridane structure and a metal complex consisting of the pincer-type ligand and a metal bound to each other, and exhibiting high reactivity and stability during a variety of bonding activation reactions. T-shaped complexes can be prepared from .sup.acriPNP(4,5-bis(diisopropylphosphino)-2,7,9,9-tetramethyl-9H-acridin-10-ide), which is a pincer-type PNP ligand having an acridane structure, and metal complexes, which can be structurally rigid and thus exhibit excellent reactivity and stability based on minimized structural change thereof, can be prepared by introducing an acridane structure into the backbone thereof. The PNP ligand is structurally stable and has novel chemical properties, as compared to conventional similar ligands, and thus can be utilized in a wide range of catalytic reactions and material chemistry.

In an embodiment, the present disclosure pertains to a method of sensing an analyte in a sample by: (1) exposing the sample to an electrode that includes a covalent-organic framework with a plurality of metal-coordinated aromatic units that are linked to one another by aromatic linkers; (2) detecting a change in a property of the electrode; and (3) correlating the change in the property to the presence or absence of the analyte. In an additional embodiment, the present disclosure pertains to said covalent-organic frameworks. Additional embodiments of the present disclosure pertain to methods of making the covalent-organic frameworks.